RARE PHOTOS: Medtech | Rare Historical Photos

Blue Star strengthens leadership as Q2 revenue jumps 21%, margins tighten

Blue Star Ltd appointed Nithianand S and Senthil Thangam as key management personnel effective November 1, 2026. The company reported a 21% rise in consolidated revenue for the September quarter, indicating strong financial health. However, profitability remains under pressure due to rising material costs and a recent inability to pass…

The Economic Times · Oct 29

Surgical Precision, Sustainable Returns: Johnson & Johnson Secures Its Cash Flow Runway

Johnson & Johnson posted Q3 revenue growth of 5.9% to $25.4 billion, raised guidance, and gained analyst support as its OTTAVA surgical system and talc settlement shape its long-term outlook.

MarketBeat · Oct 13

Is AMETEK Stock Outperforming the S&P 500?

AMETEK has outperformed the S&P 500 over the past year, and analysts are moderately optimistic about the stock’s prospects.

Barchart · Sep 10

Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity

Johnson & Johnson's post-earnings pullback follows a revenue and EPS beat, raised guidance, and analyst price target increases, with talc litigation remaining the key risk to watch.

MarketBeat · Jul 15

Silicon Valley veteran Rahul Roy plans summit to get Bengal AI-ready

Silicon Valley veteran Rahul Roy is organizing Confluence2027, a summit in San Jose from April 9-11, 2027, aimed at bridging West Bengal with the global tech hub. Focusing on AI, medtech, and economic development, the event seeks to address critical skills gaps and integrate AI innovations into the state's education.

The Times of India · Jul 2

Health services, medical education expansion to be driven by modern tech: Yogi Adityanath

Uttar Pradesh Chief Minister Yogi Adityanath reviewed health and medical education. He stressed improving treatment quality and expanding services. Medical colleges and nursing institutions will be strengthened with modern technology. Ayushman Yojana support for the poor was highlighted. Efforts are underway to enhance emergency services and control communicable diseases.

The Economic Times · May 26

Zydus Lifesciences shares soar 7% to fresh record high after Q4 results. Should you buy, sell or hold?

Zydus Lifesciences shares climbed to a new 52-week high. The company reported a 9% rise in net profit and over 16% revenue growth for the January-March quarter. A Rs 1,100 crore share buyback was announced. Analysts from Nomura, Nuvama, Motilal Oswal, and JM Financial shared their views on the company's…

The Economic Times · May 20

STERIS Q4 Earnings Call Highlights

STERIS (NYSE:STE) reported a stronger fiscal 2026 overall despite a lighter fourth quarter, with executives pointing to record annual revenue, resilient procedure demand and continued pricing gains, while also outlining expectations for mid- to high-single-digit growth in fiscal 2027. Senior Vice P

MarketBeat · May 15

Canvas Hacked Update: Who Are the Hackers and How Long Will the LMS Be Down?

A cyberattack on the Canvas LMS disrupted access to coursework and exams at major US universities during finals week, with a ransom note from ShinyHunters.

International Business Times UK · May 8

From drought to demand: Biotech IPOs roar back with Kailera and Alamar

Strong demand for GLP-1 drugs and next-gen diagnostic testing is pulling investors back into life sciences, even as AI soaks up most venture dollars.

Fortune · Apr 18